Kintara Therapeutics Inc
NASDAQ:KTRA

Watchlist Manager
Kintara Therapeutics Inc Logo
Kintara Therapeutics Inc
NASDAQ:KTRA
Watchlist
Price: 6.3 USD 2 824.79% Market Closed
Market Cap: 266.4m USD

Intrinsic Value

The intrinsic value of one KTRA stock under the Base Case scenario is 6.98 USD. Compared to the current market price of 6.3 USD, Kintara Therapeutics Inc is Undervalued by 10%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

KTRA Intrinsic Value
6.98 USD
Undervaluation 10%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Kintara Therapeutics Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about KTRA?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is KTRA valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Kintara Therapeutics Inc.

Explain Valuation
Compare KTRA to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about KTRA?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Kintara Therapeutics Inc

Current Assets 5.5m
Cash & Short-Term Investments 4.9m
Other Current Assets 619k
Non-Current Assets 674k
PP&E 674k
Current Liabilities 2.3m
Accounts Payable 2.2m
Other Current Liabilities 52k
Non-Current Liabilities 186k
Other Non-Current Liabilities 186k
Efficiency

Free Cash Flow Analysis
Kintara Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Kintara Therapeutics Inc

Revenue
0 USD
Operating Expenses
-8.5m USD
Operating Income
-8.5m USD
Other Expenses
-50k USD
Net Income
-8.5m USD
Fundamental Scores

KTRA Profitability Score
Profitability Due Diligence

Kintara Therapeutics Inc's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

Exceptional ROIC
Exceptional 3Y Average ROIC
ROIC is Increasing
Low 3Y Average Gross Margin
49/100
Profitability
Score

Kintara Therapeutics Inc's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

KTRA Solvency Score
Solvency Due Diligence

Kintara Therapeutics Inc's solvency score is 73/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
73/100
Solvency
Score

Kintara Therapeutics Inc's solvency score is 73/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

KTRA Price Targets Summary
Kintara Therapeutics Inc

There are no price targets for KTRA.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Kintara Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for KTRA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

KTRA Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one KTRA stock?

The intrinsic value of one KTRA stock under the Base Case scenario is 6.98 USD.

Is KTRA stock undervalued or overvalued?

Compared to the current market price of 6.3 USD, Kintara Therapeutics Inc is Undervalued by 10%.

Back to Top